5th NovAliX Conference “Biophysics in Drug Discovery” Boston, June 13-15, 2018
Last June, for the first time in its history the NovAliX Conference “Biophysics in Drug Discovery” took place in the world’s premier pharma hot-spot, Boston, MA. With 80 % of delegates from industry, it was widely acclaimed to be a great success within the biophysics community, echoed in the posts of Dan Erlanson (Carmot Therapeutics) on the Practical Fragment blog here and Paul Belcher (GE Healthcare) here. Outstanding speakers from AbbVie, Amgen, Arö biotherapetics, AstraZeneca, BMS, Merck & Co, Novartis, & Pfizer and were complemented by profound academic insights from Nobel laureate Pr. Martin Karplus, and scientists from The Scripps Institute and Boston University. The international spirit was alive and well with people of 15 different nationalities.
A special session was devoted to cryo-electron microscopy, the subject of the 2017 Nobel Prize for chemistry and recently featured on the front page of Nature Reviews Drug Discovery. The authors of the review include NovAliX associates Jean-Paul Renaud founding CEO, EM specialist Wen-Ti Liu, Hervé William Rémigy from Thermofisher and many other leading scientists.
https://www.nature.com/articles/nrd.2018.77
Next year’s conference travels back to Europe in Nice, France and will take place on March 20-22, 2019.